Recently, it was demonstrated that the mitochondrial outer membrane (MOM) voltage-dependent anion channel (VDAC) is the main switch between mitochondrial oxidative phosphorylation (OXPHOS) and glycolysis in malignant cells and it chould be a good target for a new generation of cancer therapy (Carre et al. 2002; Maldonado 2017). Here, VDAC1 is linked to cancer.